Pfizer offers settlement in class action over Parkinson’s drug CabaserCompany has offered to settle a class action brought by more than 150 patients in Australia who allege they were never warned about the side effects of treatment.…
EURMED launched to facilitate medicines donations in response to global appealsAn initiative described as a “step change” in the ability of the European pharmaceutical industry to donate medicines in response to global disasters or appeals for humanitarian aid has been launched.…
GlaxoSmithKline revises colour and labelling of Relvar Ellipta inhaler GlaxoSmithKline is changing the colour of its Relvar Ellipta inhaler from blue to yellow after respiratory health professionals warned that patients could be confused.…
EMA says flu vaccine is safe after deaths in ItalyThere is no evidence that Novartis’s Fluad is unsafe, the European Medicines Agency (EMA) says, after 13 deaths in Italy were reported as being associated with the influenza vaccine.…
McKesson cements acquisition of CelesioThe US healthcare services and information technology company McKesson Corporation has cemented its acquisition of German pharmaceutical wholesale and retail company Celesio AG.…
Phase I trial of GlaxoSmithKline’s Ebola vaccine shows it is well tolerated No major adverse events were reported in an Ebola vaccine phase I trial involving 20 volunteers.…
Neglected diseases research gets a boost as Merck KGaA joins consortium The German pharmaceutical company Merck KGaA has joined WIPO Re:Search consortium, a public-private consortium to help find new ways of using intellectual property (IP) for medicines and diagnostics used to treat neglected tropical diseases.…
Chief pharmacists warned of need for succession planning for procurement roles Succession planning is urgently needed to prepare for the swathe of experienced pharmacists buying medicines for hospitals who will shortly retire, an independent review has warned.…
Ibrutinib launched for treatment of mantle cell lymphoma and chronic lymphocytic leukaemia Ibrutinib, a Bruton’s tyrosine kinase inhibitor, has been launched in the UK for the treatment of mantle cell lymphoma or chronic lymphocytic leukaemia.…
Lundbeck’s chief executive resigns after code of ethics breachUlf Wiinberg has resigned as chief executive of the Danish pharmaceutical company Lundbeck after breaching the company’s code of ethics.…